Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5699582 | Clinical Oncology | 2008 | 6 Pages |
Abstract
Thirty-six per cent of patients had residual tumour locally in the testis after primary chemotherapy for metastatic GCT of the testis. However, in the cases with pure seminomatous disease, there was no residual tumour present. It may not be necessary to undertake delayed orchidectomy in these patients.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
V.A.C. Ramani, B.R. Grey, S.K. Addla, M.P. Dunham, V.K. Sangar, N.W. Clarke,